PTC Therapeutics, Inc. PTCT 深 滬
已收盤 05-22 16:00:00 美东时间
68.81
-0.980
-1.40%
華盛通- 最 高70.74
- 今 開69.59
- 成交量 71.51万股
- 最 低 68.26
- 昨 收 69.79
- 總市值 57.08亿
- 52周最高 87.50
- 市盈率 靜 8.85
- 換手率 0.86%
- 52周最低 43.175
- 委 比 -21.09%
- 總股本 8294.93万
- 歷史最高 87.50
- 量 比 0.83
- 振 幅 3.55%
- 歷史最低 4.03
- 每 手 1
- 風險率 10.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
PTC Therapeutics (PTCT) Gets a Hold from Citi
Citi analyst Geoff Meacham maintained a Hold rating on PTC Therapeutics on May ...
05-10 21:37
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson May 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, McDonald's and McKesson on Friday. HIGHLIGHTS * Applied Materials Inc AMAT.O : Berenb
05-08 15:12
PTC Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY2026 sales guidance above estimates.
PTC Therapeutics shares are trading higher after the company reported better-th...
05-08 05:26
PTC Therapeutics Lifts 2026 Outlook on Sephience Momentum
PTC Therapeutics ( ($PTCT) ) has provided an update. On May 7, 2026, PTC Therap...
05-08 05:22
Barclays Keeps Their Buy Rating on PTC Therapeutics (PTCT)
In a report released today, Eliana Merle from Barclays maintained a Buy rating ...
04-29 16:47
PTC Therapeutics Reports Positive 24-Month Votoplam Data
PTC Therapeutics ( ($PTCT) ) has shared an update. On April 28, 2026, PTC Thera...
04-29 05:19
PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study
WARREN, N.J., April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call today, April 28 at 4:30 p.m. ET to share results from the 24-month inte...
04-28 21:28
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WARREN, N.J., April 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 13, 2026, the company approved non-statutory stock options to purchase an agg...
04-18 04:30
